Editas Medicine (EDIT) PT Lowered to $7 at Evercore ISI
Tweet Send to a Friend
Evercore ISI analyst Liisa Bayko lowered the price target on Editas Medicine (NASDAQ: EDIT) to $7.00 (from $15.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
